A detailed history of Jpmorgan Chase & CO transactions in Gabelli Healthcare & Wellness Rx Trust stock. As of the latest transaction made, Jpmorgan Chase & CO holds 225 shares of GRX stock, worth $2,313. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225
Previous 225 -0.0%
Holding current value
$2,313
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$8.57 - $10.12 $5,253 - $6,203
-613 Reduced 73.15%
225 $1,000
Q2 2023

Aug 11, 2023

SELL
$9.5 - $10.34 $4,645 - $5,056
-489 Reduced 36.85%
838 $8,000
Q1 2023

May 11, 2023

BUY
$9.49 - $10.56 $10,457 - $11,637
1,102 Added 489.78%
1,327 $13,000
Q3 2021

Nov 12, 2021

BUY
$13.11 - $14.07 $2,949 - $3,165
225 New
225 $3,000

Others Institutions Holding GRX

About Gabelli Healthcare & WellnessRx Trust


  • Ticker GRX
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of co...
More about GRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.